SavedAdd your journal

Journals / Gülhane Tıp Dergisi / 2015 / Cilt: 57 - Sayı: 2

Fetal demise despite successful medical conversion of supraventricular tachycardia causing hydrops and acceptable fetal cardiovascular profile score: case report

Supraventriküler taşikardiye sekonder gelişen yüksek kardiyo- vasküler profil skora sahip hidropslu fetusun başarılı maternal antiaritmik tedaviye rağmen kayıbı: Olgu sunumu

YILMAZ YOZGAT
Seçil KURTULMUŞ
Cüneyt Eftal TANER
Taliha ÖNER
Önder DOKSÖZ
Rahmi ÖZDEMİR
Timur MEŞE
Pages
170–172
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CVPS score could be misleading in determination of prognosis in hydrops fetalis secondary to SVT

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Fetal tachyarrhythmia is a well-recognized cause of non-immune hydrops fetalis.
📊
Key Findings & Data:We report here a case of severe hydrops secondary to supraventricular tachycardia (SVT) detected in 28 weeks of gestation.
💡
Conclusion & Impact:CVPS score could be misleading in determination of prognosis in hydrops fetalis secondary to SVT
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Fetal tachyarrhythmia is a well-recognized cause of non-immune hydrops fetalis. Without treatment, it may progress to hydrops fetalis and in utero fetal death. The prognosis of hydrops fetalis is highly dependent on rapid response to antiarrhythmic therapy, gestational age, fetal well being and high cardiovascular profile score (CVPS). We report here a case of severe hydrops secondary to supraventricular tachycardia (SVT) detected in 28 weeks of gestation. We presented this case to discuss CVPS. Maternally administered drug combinations including digoxin and sotalol successfully converted the disordered cardiac rhythm to sinus rhythm within 1 day. However, the fetal health failed to improve, hydrops fetalis worsened and the fetus died in utero after 21 days of treatment. The fetal CVPS was 7/10 (2 points deducted for skin edema, 1 for ductus venosus atrial reversal). It was a score, which is considered compatible with life. However, the fetus died despite an acceptable average CVPS score of 7. CVPS score could be misleading in determination of prognosis in hydrops fetalis secondary to SVT

Özet

Fetal taşikardi en iyi bilinen non-immun hidrops fetalis nedenidir. Fetal taşikardi tedavi edilmezse hidrops fetalise ve fetal kayıba neden olabilmektedir. Hidrops fetaliste prognoz antiaritmik tedaviye hızlı yanıta, gebelik haftasına, fetusun iyilik haline ve yüksek kardiyovasküler profil skora (KVPS) bağlıdır. Biz burada SVT' ye sekonder gelişen 28 haftalık hidropslu fetusu olgu olarak sunduk. Biz KVPS'u tartışmak amacıyla bu olgu sunumunu sunduk . Olgumuz da Digoksin ve sotalol den oluşan kombine maternal antiaritmik tedavinin 1. günde fetal taşikardinin başarılı şekilde sinüs ritmine dönüştüğü izlendi fakat fetusun iyilik hali gittikçe bozulup hidrops fetalis ağırlaştı ve tedavinin 21. günü fetal kayıp gerçekleşti. Fetusun kardiyovasküler profil skoru (KVPS) 7/10 ( cilt ödemi 2 puan, duktus venozusta revers atriyal A dalgası 1 puan kayıp) idi. Ve bu yaşamla bağdaşır kabul edilebilir bir skordu. Fakat olgumuzda hayatla bağdaşır (7/10) KVPS olmasına rağmen fetal kayıp oluşmuştur. Kardiyovasküler profil skor SVT'ye sekonder gelişen hidrops fetalisin prognozunu belirlenmede yanıltıcı olabilir

🔖

Cite This Article

YOZGAT, Y., KURTULMUŞ, S., TANER, C. E., ÖNER, T., DOKSÖZ, Ö., ÖZDEMİR, R., MEŞE, T. (2015). Fetal demise despite successful medical conversion of supraventricular tachycardia causing hydrops and acceptable fetal cardiovascular profile score: case report. Gülhane Tıp Dergisi, Cilt: 57 - Sayı: 2, 170–172. https://ajindex.com/articles/204335

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Oudijk MA, Visser GH, Meijboom EJ. Fetal Tachyarrhy- thmia - Part 1: Diagnosis. Indian Pacing Electrophysiol J 2004;4:104. Oztunc f. Fetal dysrhythmias. Turkiye Klinikleri J Pediatr Sci 2010;6: 77-81.
  2. Hofstaetter C, Hansmann M, Eik-Nes SH, Huhta JC, Luther SL. A cardiovascular profile score in the surve- illance of fetal hydrops. J Matern Fetal Neonatal Med 2006;19:407-13.
  3. Wieczorek A, Hernandez-Robles J, Ewing L, Leshko J, Luther S, Huhta J. Prediction of outcome of fetal conge- nital heart disease using a cardiovascular profile score. Ultrasound Obstet Gynecol 2008;31:284-8.
  4. Cuneo, B. F. & Strasburger, J. F. Management strategy for fetal tachycardia. Obstet. Gynecol 2000. 96(4):575- 81. Strasburger JF. Prenatal Diagnosis of Fetal Arrhythmi- as. Clin Perinatol 2005;32:891-912,
  5. Rana Y.S, Sodhi B, Kochar SPS,D Arora. Successful Digoxin Therapy of Fetal Supraventricular Tachycardia,South Asian Federation of Obstetrics and Gynecology 2009;1(1):44-46
  6. Oudijk MA, Visser GH, Meijboom EJ, Fetal Tachyarrhy- thmia - Part 2: Treatment, Indian Pacing Electrophysiol J 2004;4(4):185-94
  7. Merriman JB, Gonzalez JM, Rychik J. Can digoxin and sotalol therapy for fetal supraventricular tachycardia and hydrops be successful? A case report. J Reprod Med 2008;53:357-9.
  8. Falkensammer CB, Paul J, Huhta JC. Fetal congestive heart failure: orrelation of Tei-index and Cardiovascular- score. J Perinat Med 2001; 29 (5): 390-398.
  9. Hofstaetter C, Huhta JC. Outcome assessment in hydrops fetalis using a cardiovascular score. Poster pre- sentation at the Society of Pediatric Research,Baltimore, MD; May 7, 2002
  10. Makikallio K, Vuolteenaho O, Jouppila P, Rasanen J. Association of severe placental insufficiency and syste- mic venous pressure rise in the fetus with increased ne- onatal cardiac troponin T levels. Am J Obstet Gynecol 2000;183(3):726-31.
  11. Wieczorek A, Hernandez-Robles J, Ewing L, Leshko J, Luter S, Huhta J. Prediction of outcome of fetal conge- nital heart disease using a cardiovascular profile score. Ultrasound Obstet Gynecol 2008; 31(3): 284-288.